- Home
- MLSS vs MRSN Comparison
MLSS vs MRSN Comparison
Compare MLSS & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLSS
- MRSN
- Stock Information
- Founded
- MLSS 1989
- MRSN 2001
- Country
- MLSS United States
- MRSN United States
- Employees
- MLSS N/A
- MRSN N/A
- Industry
- MLSS Industrial Specialties
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- MLSS Health Care
- MRSN Health Care
- Exchange
- MLSS Nasdaq
- MRSN Nasdaq
- Market Cap
- MLSS 42.4M
- MRSN 37.0M
- IPO Year
- MLSS 1995
- MRSN 2017
- Fundamental
- Price
- MLSS $0.59
- MRSN $7.32
- Analyst Decision
- MLSS Buy
- MRSN Strong Buy
- Analyst Count
- MLSS 1
- MRSN 4
- Target Price
- MLSS $1.25
- MRSN $63.67
- AVG Volume (30 Days)
- MLSS 903.4K
- MRSN 97.8K
- Earning Date
- MLSS 08-14-2025
- MRSN 08-13-2025
- Dividend Yield
- MLSS N/A
- MRSN N/A
- EPS Growth
- MLSS N/A
- MRSN N/A
- EPS
- MLSS N/A
- MRSN N/A
- Revenue
- MLSS $9,083,205.00
- MRSN $34,769,000.00
- Revenue This Year
- MLSS $17.24
- MRSN N/A
- Revenue Next Year
- MLSS $14.58
- MRSN N/A
- P/E Ratio
- MLSS N/A
- MRSN N/A
- Revenue Growth
- MLSS 7.84
- MRSN 16.14
- 52 Week Low
- MLSS $0.38
- MRSN $5.21
- 52 Week High
- MLSS $1.39
- MRSN $70.75
- Technical
- Relative Strength Index (RSI)
- MLSS 47.69
- MRSN 48.13
- Support Level
- MLSS $0.57
- MRSN $7.41
- Resistance Level
- MLSS $0.65
- MRSN $8.05
- Average True Range (ATR)
- MLSS 0.04
- MRSN 0.60
- MACD
- MLSS 0.00
- MRSN 0.10
- Stochastic Oscillator
- MLSS 45.31
- MRSN 70.73
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.